Click Ctrl+F (On Windows) or Cmd+F (On Mac) to look for word of interest, or find latest FAQs on top of each section.
Updated 30 Jul 2021

Special Access Route (SAR) Vaccines

 [Updated 2 Jul 21] Is the Sinovac vaccine free to everyone who opts for it? How will the government reimburse me for the vaccination fee?
A:Only if you were previously rejected from taking the mRNA vaccines because you had severe allergies or were allergic to the first dose. You can go to any of the approved private clinics to get vaccinated with the Sinovac vaccine for free. It will be hassle-free and you do not need to pay. 
For all other individuals who prefer Sinovac for non-medical reasons, it will be a private arrangement with the vaccine provider, and will have to pay an admin fee to the private providers. 

The list of selected providers and their vaccination administration fee per dose of the Sinovac-CoronaVac vaccine is listed here (updated 2 Jul).

 [Updated 30 Jul 21] If Sinovac is safe enough to be allowed for use, under the Special Access Route (SAR), why is it not part of the national vaccination programme and covered by the Vaccine Injury Financial Assistance Programme (VIFAP)?
A:These are two separate decisions.
For vaccines to come under the national vaccination programme, it has to go through a rigorous evaluation of its safety and efficacy. From global and local data, both the Pfizer-BioNTech/ Comirnaty and Moderna vaccines met these criteria.
In the meantime, we will put the Sinovac vaccine under the Special Access Route, so that private providers can draw on our existing stock to administer to individuals who wish to have it.
 What about those who had severe adverse reactions after their first dose of the Pfizer-BioNTech/ Comirnaty or Moderna vaccine? Can they opt for other vaccines on the SAR?
A:Yes, there are some 2,000 individuals in this category. They  should not receive an mRNA vaccine again.
To protect them against COVID-19, we are also evaluating other suitable non-mRNA vaccines. We expect to make such vaccines available before the end of this year for use in our national vaccination programme, after the vaccines have been rigorously assessed and approved by the HSA. However, if this group of individuals are unable to wait for the alternative non-mRNA vaccines, they can consider taking non-HSA authorised vaccines under the SAR such as Sinovac.

Click the back button on your browser or click here for the main page on FAQs.